glp-1 drugs heart failure The effect of receptor agonists on cardiac remodeling in patients with preserved and reduced ejection fraction: a systematic review and meta-analysis | Heart Failure Reviews GLP-1RA in Different HFpEF Phenotypes

The European Cardiovascular Health Plan Roadmap from the European Alliance was published earlier in 2025 and calls for comprehensive approaches to incorporate the recognition of obesity as a trigger for cardiovascular disease

Adverse psychiatric effects associated with GLP-1 RAs, including depression, anxiety, and suicidal ideation, are noted in pharmacovigilance analyses, with variations among different GLP-1 RAs

We take a personalized, medically guided approach to ensure safe and effective results.

Can I Take Semaglutide GLP-1 If I Am Not Diabetic?

This analytical review critically examines the evidence surrounding GLP-1 agonists efficacy, safety, and real-world implications for obesity treatment in individuals without diabetes

GLP-1 and its synthetic analogs have emerged as significant therapeutic agents for the management of metabolic disorders, merging glycemic control with weight loss through innovative structural and delivery breakthroughs